Investing in biotechnology stocks is complex due to the science behind the company’s drug candidates. They can be difficult to trade because these stocks are highly volatile, with double-digit moves in both directions a common occurrence.
However, biotech stocks offer a compelling risk-reward proposition as a long-term investment. The payoff in these three stocks can be massive for investors with the patience and time to hold them through the clinical trial phase.
